MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The Clinical Implication of Dysphagia in Patients with Multiple System Atrophy

    MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to explore the correlation between dysphagia and key clinical features in Multiple System Atrophy (MSA) patients, along with investigating the link…
  • 2024 International Congress

    Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

    N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

    Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
  • 2024 International Congress

    The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, A. Drzewińska, K. Duszyńska-Wąs, A. Wiercińska-Drapało, M. Struga, N. Madetko-Alster (Warszawa, Poland)

    Objective: The goal of the research was to verify the possible association between the levels of inflammatory factors and frontal deficits in Progressive Supranuclear Palsy…
  • 2024 International Congress

    Progressive freezing of gait in atypical parkinsonism. A Possible Progressive Supranuclear Palsy phenotype.

    H. Pacheco Mendoza, L. Nuñez Orozco, A. Negrete Gomez, J. Delgado Uriarte, C. Gómez Rubio (Mexico, Mexico)

    Objective: Report a case of progressive freezing of gait diagnosed as a Possible Progressive Supranuclear Palsy phenotype Progressive Gait Freezing. Background: PSP is the most…
  • 2024 International Congress

    Mild Behavioral Impairment in Lewy body disease: a potential marker of phenoconversion and disease severity

    B. Jin, E. Yoon, S. Kim, S. Lee, H. Nam, Y. Kim, B. Jeon, J. Lee (Seoul, Republic of Korea)

    Objective: To explore the association between mild behavioral impairment (MBI) and disease severity in a predefined prospective cohort with Lewy body disease (LBD) spectrum Background:…
  • 2024 International Congress

    Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

    S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)

    Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…
  • 2024 International Congress

    Early Dementia with Lewy Bodies and Parkinson’s Disease with RBD: two faces of the same coin?

    B. Orso, P. Mattioli, F. Famà, F. Massa, M. Pardini, A. Brugnolo, N. Girtler, S. Raffa, L. Sofia, S. Morbelli, D. Arnaldi (Genoa, Italy)

    Objective: To describe clinical and imaging differences in de novo PD with and without REM sleep Behaviour Disorder (dnPDRBD – de novo PD) and de…
  • 2024 International Congress

    Clinical Utility of Synuclein Skin Biopsy in the Initial Diagnosis and Evaluation of Parkinsonian Disorders

    J. Isaacson, R. Freeman, C. Gibbons, A. Alshehri (Boston, USA)

    Objective: To determine the clinical utility of phosphorylated alpha-synuclein (P-SYN) within skin biopsies in diagnostic and management decisions. Background: The initial diagnosis of Parkinson’s Disease…
  • 2024 International Congress

    Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series

    M. Gaitan-Palau, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: This study aims to identify the main symptoms associated with the clinical diagnosis of parkinsonism, excluding Parkinson's disease (PD), among patients evaluated by non-specialist…
  • 2024 International Congress

    Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

    N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)

    Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley